Charles River Laboratories CRL Redeemable Noncontrolling Interest, Decrease from Redemptions or Purchase of Remaining Equity Interest
Redeemable Noncontrolling Interest, Decrease from Redemptions or Purchase of Remaining Equity Interest at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept crl:RedeemableNoncontrollingInterestDecreaseFromRedemptionsOrPurchaseOfRemainingEquityInterest.
The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's redeemable noncontrolling interest, decrease from redemptions or purchase of remaining equity interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's redeemable noncontrolling interest, decrease from redemptions or purchase of remaining equity interest?
- Charles River Laboratories (CRL) reported redeemable noncontrolling interest, decrease from redemptions or purchase of remaining equity interest of -$287.75K in Q4 2023.
- What does redeemable noncontrolling interest, decrease from redemptions or purchase of remaining equity interest mean?
- The reduction in minority equity liability following a full buyout of remaining minority interests.
- How do you interpret redeemable noncontrolling interest, decrease from redemptions or purchase of remaining equity interest?
- Signals the transition of a subsidiary to a wholly-owned entity.
- How does redeemable noncontrolling interest, decrease from redemptions or purchase of remaining equity interest compare across companies?
- Occurs during final stages of subsidiary integration.